Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alto Neuroscience (ANRO) Assets Average (2024 - 2026)

Alto Neuroscience has reported Assets Average over the past 3 years, most recently at $230.5 million for Q1 2026.

  • Quarterly results put Assets Average at $230.5 million for Q1 2026, up 31.9% from a year ago — trailing twelve months through Mar 2026 was $230.5 million (up 31.9% YoY), and the annual figure for FY2025 was $181.1 million, up 37.12%.
  • Assets Average reached $230.5 million in Q1 2026 per ANRO's latest filing, up from $165.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $230.5 million in Q1 2026 and bottomed at $148.3 million in Q1 2024.
  • Median Assets Average over the past 3 years was $174.7 million (2025), compared with a mean of $179.9 million.
  • The largest annual shift saw Assets Average dropped 21.62% in 2025 before it skyrocketed 31.9% in 2026.
  • Over 3 years, Assets Average stood at $184.6 million in 2024, then fell by 10.15% to $165.8 million in 2025, then skyrocketed by 38.97% to $230.5 million in 2026.
  • Business Quant data shows Assets Average for ANRO at $230.5 million in Q1 2026, $165.8 million in Q4 2025, and $152.4 million in Q3 2025.